close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Suletud

72.33 1.79

Tugev "osta" hinnang

Hinna uuendus 5. märts 2026, 20:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

70.72

Max

74.54

Põhinäitajad

By Trading Economics

Sissetulek

6.1M

-36M

Müük

615K

12M

Aktsiakasum

-1.87

Kasumimarginaal

-301.289

Töötajad

61

EBITDA

6.9M

-29M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+82.62% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

12. märts 2026

Turustatistika

By TradingEconomics

Turukapital

773M

1.9B

Eelmine avamishind

70.54

Eelmine sulgemishind

72.33

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. märts 2026, 23:01 UTC

Tulu

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

DJ

Loe

5. märts 2026, 21:54 UTC

Tulu

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

DJ

Loe

5. märts 2026, 21:35 UTC

Suurimad hinnamuutused turgudel

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

DJ

Loe

6. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

DJ

Loe

5. märts 2026, 23:46 UTC

Market Talk

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

DJ

Loe

5. märts 2026, 23:33 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

DJ

Loe

5. märts 2026, 23:27 UTC

Market Talk

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

DJ

Loe

5. märts 2026, 22:54 UTC

Market Talk
Tulu

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

DJ

Loe

5. märts 2026, 22:50 UTC

Market Talk

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

DJ

Loe

5. märts 2026, 22:48 UTC

Tulu

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

DJ

Loe

5. märts 2026, 22:46 UTC

Tulu

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

DJ

Loe

5. märts 2026, 22:44 UTC

Tulu

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

DJ

Loe

5. märts 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

5. märts 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

5. märts 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Loe

5. märts 2026, 21:35 UTC

Tulu

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

DJ

Loe

5. märts 2026, 21:32 UTC

Tulu

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

DJ

Loe

5. märts 2026, 21:26 UTC

Tulu

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

DJ

Loe

5. märts 2026, 21:24 UTC

Tulu

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

DJ

Loe

5. märts 2026, 21:23 UTC

Tulu

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

DJ

Loe

5. märts 2026, 21:22 UTC

Tulu

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

DJ

Loe

5. märts 2026, 21:21 UTC

Tulu

Costco February Digitally-Enabled Sales Rose 21.8% >COST

DJ

Loe

5. märts 2026, 21:21 UTC

Tulu

Costco Total Co Comparable Sales for February Rose 7.9% >COST

DJ

Loe

5. märts 2026, 21:20 UTC

Tulu

Costco February Net Sales Were $21.69 B >COST

DJ

Loe

5. märts 2026, 21:20 UTC

Tulu

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

DJ

Loe

5. märts 2026, 21:20 UTC

Tulu

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

DJ

Loe

5. märts 2026, 21:19 UTC

Tulu

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

DJ

Loe

5. märts 2026, 21:18 UTC

Tulu

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

DJ

Loe

5. märts 2026, 21:18 UTC

Tulu

Costco 2Q Same-Store Sales Up 7.4% >COST

DJ

Loe

5. märts 2026, 21:15 UTC

Tulu

Costco 2Q EPS $4.58 >COST

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

82.62% tõus

12 kuu keskmine prognoos

Keskmine 129.86 USD  82.62%

Kõrge 165 USD

Madal 102 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

8

Osta

0

Hoia

0

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

981.29

↓-2.24%

JNJ

Johnson and Johnson

239.53

↓-2.3%

ABBV

AbbVie Inc

232.07

↓-1.66%

NVS

Novartis AG

160.95

↓-2.49%

AZN

AstraZeneca PLC

197.36

↓-2.11%
help-icon Live chat